Blog
Regulation, Confusion, and the Irony of Emergency COVID-19 Testing
By now, readers are aware that testing in the United States for the novel coronavirus COVID-19 has been embarrassingly slow. Less well known is that…
Blog
HHS Price Disclosure Rule Will Not Make Medicines More Affordable
In his State of the Union Address, President Trump renewed his commitment to “lower[ing] the cost of health care and prescription drugs” and “requir[ing] drug…
Blog
New Drug Price Proposal Light on Competition, Heavy on Bureaucracy
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs.
Blog
Letter to Congress: Experts Urged House to Reject Mandatory GMO Labeling Bill
In advance of a House vote on July 14 concerning mandatory GMO labeling, myself and other policy experts on biotechnology, consumer, and agricultural policy sent…
Blog
Nobel Prize Winners Denounce Greenpeace Opposition to GMOs
For decades, the environmental activist group Greenpeace has been among the most vocal, and oftentimes vicious, opponents of biotechnology and genetically engineered crops.
Blog